Lilly Is Selling Zepbound Vials at 50% Discount to Shots (5)

Aug. 27, 2024, 9:44 PM UTC

Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.

Patients with a prescription for Zepbound can purchase a month’s supply of single-use vials through Lilly’s direct-to-consumer site starting Tuesday, the company said in a statement. The vials are priced at about half of what shots cost, with a higher dose going for $549 a month.

Zepbound is typically sold in an auto-injector pen. With vials, patients need to fill syringes on their own but ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.